# Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens

> **NCT00838045** · PHASE4 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 125 (actual)

## Conditions studied

- Cataract
- Aphakia

## Interventions

- **DEVICE:** The Bausch & Lomb Akreos TL IOL (MI60) posterior chamber IOL

## Key facts

- **NCT ID:** NCT00838045
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-04
- **Final completion:** 2008-09
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2011-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00838045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00838045, "Evaluation of the Safety & Effectiveness of the Bausch & Lomb AKREOS® TL Intraocular Lens". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00838045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*